UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. _____)*


(Name of Issuer)
Benda Pharmaceutical, Inc.

(Title of Class of Securities)
Common

(CUSIP Number)
08165P108

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

David Hill
Pope Asset Management, LLC
5100 Poplar Avenue Suite 805
Memphis TN  38137
901-763-4001

(Date of Event which Requires Filing of this Statement) 12/31/2010

If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject
of this Schedule 13D, and is filing this schedule
because of 240.13d-1(e), 240.13d-1(f)
or 240.13d-1(g), check the following box. [   ]
Note: Schedules filed in paper format shall include a
signed original and five copies of the schedule,
including all exhibits. See 240.13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the
subject class of securities, and for any subsequent
amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to
the liabilities of that section of the Act but
shall be subject to all other provisions of
the Act (however, see the Notes).


CUSIP No 08165P108


1.
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).
Pope Asset Management LLC  62-1871308

2.
Check the Appropriate Box if a Member of a Group (See Instructions)

(a)
(b)

3.
SEC Use Only

4.
Source of Funds (See Instructions) OO

5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)


6.
Citizenship or Place of Organization Tennessee USA

Number of Shares Beneficially Owned by Each Reporting Person With

7.
Sole Voting Power 22,337,998*

8.
Shared Voting Power 0

9.
Sole Dispositive Power  22,337,998*

10.
Shared Dispositive Power 0


11.
Aggregate Amount Beneficially Owned by Each Reporting Person
22,337,998*

*The amount reported above includes aggregate of ownerhsip by
Pope Asset Management, LLC and Pope Investments LLC.  Pope Asset
Management, LLC is the investment adviser for Pope Investments LLC.
Pope Investments LLC owns 22,337,998 shares of Benda Pharmaceutical, Inc.
Therefore, Pope Asset Management, LLC, as investment advisor to Pope
Investments LLC could be deemed to be beneficial owners of 22,337,998
shares of Benda Pharmaceutical Inc.

12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)


13.
Percent of Class Represented by Amount in Row (11) 21.24%


14.
Type of Reporting Person (See Instructions)
IA



1.
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).

Pope Investments LLC  20-3955985


2.
Check the Appropriate Box if a Member of a Group (See Instructions)

(a)
(b)


3.
SEC Use Only

4.
Source of Funds (See Instructions) OO

5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)

6.
Citizenship or Place of Organization Delaware, USA

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With

7.
Sole Voting Power 22,337,998

8.
Shared Voting Power 22,337,998

9.
Sole Dispositive Power  22,337,998

10.
Shared Dispositive Power 22,337,998


11.
Aggregate Amount Beneficially Owned by Each Reporting Person
22,337,998


12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)


13.
Percent of Class Represented by Amount in Row (11) 21.24%


14.
Type of Reporting Person (See Instructions)
00


1.
Names of Reporting Persons. I.R.S. Identification Nos. of above persons
(entities only).
William P. Wells      426961338



2.
Check the Appropriate Box if a Member of a Group (See Instructions)

(a)
(b)


3.
SEC Use Only

4.
Source of Funds (See Instructions) OO

5.
Check if Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e)


6.
Citizenship or Place of Organization Tennessee USA

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With

7.
Sole Voting Power 22,337,998*

8.
Shared Voting Power 0

9.
Sole Dispositive Power  22,337,998*

10.
Shared Dispositive Power 0


11.
Aggregate Amount Beneficially Owned by Each Reporting Person
22,337,998*


*The amount reported above includes aggregate of ownerhsip by
Pope Asset Management, LLC and Pope Investments LLC.  William P. Wells
is Chief Manager of Pope Asset Management, LLC.  Pope Asset Management, LLC
is the investment adviser for Pope Investments LLC.  Pope Investments LLC
owns 22,337,998 shares of Benda Pharmaceutical, Inc.  Therefore, William
P. Wells as Chief Manager of Pope Asset Management, LLC, which serves
as investment advisor to Pope Investments LLC could be deemed to be
beneficial
owner of 22,337,998 shares of Benda Pharmaceutical Inc.

12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)


13.
Percent of Class Represented by Amount in Row (11) 21.24%


14.
Type of Reporting Person (See Instructions)
IN


Item
1.
Security and Issuer
Common shares of Benda Pharmaceutical, Inc whose principal address is
Changjiang Tower, 23rd Fl, No. 1 Minquan Road, Wuhan,
Hubai Province, China.

Item
2.
Identity and Background
(a)
This 13-D Form is filed by and on behalf of: (i) Pope Asset
Management, LLC, a Tennessee limited liability
company ("Pope Asset"), (ii) Pope Investments LLC,
a Delaware limited liability company
("Pope Investments"); and (iii) William P. Wells ("Mr. Wells").
This statement updates that certain Schedule 13 D initially filed by and
on behalf of Pope Asset on April 16, 2007.  Pope Asset is a registered
investment adviser and serves as an investment adviser and/or manager
to various persons, including Pope Investments.  Pope Asset is the sole
manager for Pope Investments and has sole voting control and investment
and disposition power and discretion with respect to all securities held
by Pope Investments. The securities of the issuer
reported in this statement were purchased at various
times by Pope Asset, in its capacity as the sole
manager of Pope Investments, for the account of and in the name of Pope
Investments.  Pope Asset may be deemed to beneficially own shares owned
and/or held by and for the account of and/or benefit of various persons,
including Pope Investments.  Mr. Wells is the sole manager of Pope Asset.
Mr. Wells may be deemed to own shares owned and/or held by and/or for the
account of and/or benefit of Pope Investments. Pope Asset,
Pope Investments and Mr. Wells each declares that neither
the filing of this statement nor anything herein shall be
construed as an admission that such
reporting person is,for the purposes of
Section 13(d) or 13 (g) of the Act or any other
purpose, the beneficial owner of any securities
covered by this statement. Each of Pope Asset, Pope Investments
and Mr. Wells may be deemed to be a member of a group with respect
to the issuer or securities of the issuer for the purposes of
Section 13(d) or 13(g) of the Act.
Each of Pope Asset, Pope Investments and Mr. Wells declares that
neither the filing of this statement nor anything herein shall be
construed as an admission that such person is, for the purposes of
Section 13(d) or 13(g) of the Act or any other purpose, (i) acting
(or has agreed or is agreeing to act together with any other person)
as a partnership, limited partnership, syndicate, or other group for
the purpose of acquiring, holding, or disposing of securities of the
issuer or otherwise with respect to the issuer or any securities of
the issuer, or (ii) a member of any group with respect tothe issuer
or any securities of the issuer.

(b)
5100 Poplar Avenue, Suite 805, Memphis, TN  38137

(c)
See Item 2a above.

(d)
not applicable

(e)
not applicable

(f)
Citizenship.  Pope Asset in a Tennessee limited liability company.
Pope Investments is a Delaware limited liability company. William P. Wells
is a citizen of the United States of America.

Item
3.
Source and Amount of Funds or Other Consideration
The source of all funds invested in Benda Pharmaceutical, Inc.
were funds from Pope Investments.  As reported in the Schedule 13 D
filed by Pope Asset on March 16, 2007, the initial transaction in securities
of the issuer for which the initial Schedule 13 D was filed consisted
of the Common Stock and warrants to purchase stock of Benda
Pharmaceutical, Inc. (formerly known as Applied Spectrum Technologies).
The parties to the initial transaction included:
Keating Investments, LLC - broker/dealer, Accelera Ventures Limited,
Lars B. Ahlstrom, Anima S.G.R.p.A.
Rubrica - Anima Asia, Anima S.G.R.p.A. Rubrica - Anima Emerging Markets,
Banca Gesfid, Joseph F. Barletta, BH Capital Investments LP,
David L. Dowler, Victor J. Dowling Jr. & Jody C. Dowling, Excalibur
Limited Partnership, Excalibur Limited Partnership II,
F Berdon Co LP, Elaine P. Fields,James W. Fuller, Joseph W. Grealish,
David Austin Grose, Halter Pope USX China Fund, Linda Hechter,
Hedge Capital Partners LLC, Mark and Stacia Hollmann as Tenants
by the Entirety, Scot C. Hollmann,Jayhawk Private Equity Fund, L.P.,
John K. Kopra, Peter Levy,LKCM Private Discipline Master Fund, SPC,
Suresh Madan & Sarita Madan, Paul Masters IRA, Christopher McCarty &
Jennifer Grey McCarty,
MCF Navigator Master Fund, Ltd., Edmund H. Melhado,
Gabriel Micek, John Micek, Jordan Micek,
Maurice & Jennifer Micek JTWROS, Peter Micek,
MidSouth Investor Fund LP, Nite Capital LP, Michael J.
O'Halloran,Stephen B. Olore, Jerry W. Peterson, Pope Investments LLC,
Professional Offshore Opportunity Fund, Ltd.,
Steven R. Purvis, RFJM Partners LLC,
Rock Associates, Marvin Rosenfield, Steven Rothstein,
Don Russell, Silver Rock I, Ltd., Silicon Prairie Partners,
Simgest SpA, Richard Todd Truitt, Jonathan Ungar,
White Sand Investor Group, LP, and Steven Zelinger &
Lisa Gordon JTWROS (collectively, the "Buyers" and each a "Buyer").

No part of the purchase price paid by Pope Investments with respect
to the transaction noted above is represented by funds or other
consideration borrowed or otherwise obtained for
purpose of acquiring, holding, trading or voting the securities.
The amount of funds invested by Pope Investments were
acquired by a series of transactions from
November 2006 to December 2007.

This report, among other matters, notes the receipt
of an additional 6,847,766 shares of the issuers
securities as part of the make good provision stipulated in the various
investment agreements for total aggregate investment
of $0.  The source of all additional funds invested in Benda
Pharmaceutical, Inc. were funds from Pope Investments. No part of the
purchase price paid by Pope Investments for the additional securities of the
issuer is represented by funds or other consideration borrowed or otherwise
obtained for purpose of acquiring, holding, trading or voting the securities.
The amount of funds invested by Pope Investments was acquired
by a series of transactions from November 2006 to December 2007.

Item
4.
Purpose of Transaction
The purpose of all of the acquisition of securities of the issuer
was and remains to be for investment purposes only.


Describe any plans or proposals which the reporting persons may have which
relate to or would result in:

(a) The Reporting Persons currently have no plan or intent to acquire
additional securities of the issuer, but may do so.

The Reporting Persons have no current intent to sell securities of the
issuer, but may do so.  Pope Investments has certain registration rights
granted by the issuer with respect to securities of the issuer
which it holds or may acquire or holds or may acquire upon
conversion of convertible notes or exercise of warrants.

(b)  Not Applicable.

(c)  Not Applicable

(d)  We have filed a complaint in the Chancery Court of Deleware.
This entails our intent to have a receiver appointed per the courts decision
after trial in March, 2010. On December 15, 2010, the Vice Chanellor
ruled that appointment of receiver is not granted at this time. We
have not pursued additional remedies at this time but may do so in the
future which may mean material changes.

(e)  Not Applicable.

(f)  Not Applicable.

(g)  Not Applicable.

(h)  Not Applicable.

(i)  Not Applicable.

(j)  The Reporting Persons are engaged in the investment business.
In pursuing this business, the Reporting Persons analyze the operations,
capital structure and markets of companies, including the issuer, on a
continuous basis through analysis of documentation and discussions
with knowledgeable industry and market observers and with representatives
of such companies, including without limitation, the issuer.
From time to time one or more of the Reporting Persons may hold
discussions with third parties or with management of such companies
in which the Reporting Person may suggest or take a position or offer
advice with respect to potential changes in the operations, management or
capital structure of such companies as a means of enhancing
shareholder value.  Such suggestions or positions may relate
to one or more of the transactions specified in clauses
(a) through (j) of this Item 4, including without limitation,
such matters as disposing of or selling all or a portion of
the company or acquiring another company
or business, changing operating or marketing strategies,
adopting or not adopting certain types of anti-takeover
measures and restructuring the issuers capitalization or dividend policy.


Item
5.
Interest in Securities of the Issuer

(a)  As of the date hereof,
Pope Investments beneficially owns (i) 22,337,998
shares of the issuer's common stock, (ii) warrants which may be
exercised for a total of 21,818,452 shares of the issuer's
common stock, and (iii) $6,180,000 of convertible promissory notes
which may be converted into a total of
11,141,922 shares of the issuer's common stock.
Therefore, Pope Investments
may be deemed to beneficially own 54,108,458 shares of the issuer's
common stock which represents approximately 51.46% of the issuer's
outstanding common stock (assuming the full exercise of the warrants
and the full conversion of the convertible notes).
The calculation of the foregoing percentage is on the
basis of 105,155,355 shares of the issuer's common stock
outstanding as disclosed in the issuer's
Form 10-Q for the quarter ended September 30, 2010 as filed on
November 19, 2010.
Pope Asset, as the manager of Pope Investments,
may also be deemed to beneficially own the above described
securities of the issuer owned by Pope Investments.

Mr. Wells, as the manager of Pope Asset, may also be deemed to
beneficially own the above-described securities of the issuer
beneficially owned by Pope Asset.The foregoing should not
be construed in and of itself as an admission by Pope Asset
or Mr. Wells as to the beneficial ownership of securities of the
issuer held by Pope Investments.
(b)  Pope Investments may be deemed to hold shared power to
vote and to dispose of the 54,108,458 shares of common stock
described in (a) above.  Pope Asset and Mr. Wells may be deemed
to hold shared power to vote and to dispose of the 54,108,458
shares of the issuer's common stock described in (a) above.
The foregoing should not be construed in and of itself as an
admission by Pope Asset or Mr. Wells as to the beneficial ownership
of the securities of the issuer held by Pope Investments.

(c)  None.

(d)  No person other than the Reporting Persons is known to have
the right to receive, or the power to direct the receipt of,
dividends from,or proceeds from the sale of, the shares
of issuer's common stock reported in this statement.

(e)  Not Applicable.

Pope Asset and Mr. Wells do not directly own any shares of the
issuer's Common Stock. Pope Asset is the sole Manager of Pope
Investments.  Mr. Wells is the Manager of Pope Asset.
Pope Asset may be deemed to beneficially own shares owned
and/or held by and for the account of and/or benefit
of various persons, including Pope Investments.
Mr. Wells may be deemed to own shares owned
and/or held by and/or for the account of and/or benefit
of Pope Investments. Each of the reporting persons declares
that neither the filing of this statement nor anything
herein shall be construed as an admission that
such reporting person is, for the purposes of Section
13(d) or 13(g) of the Act or any other purpose,
the beneficial owner of any securities
covered by this statement.

Item
6.
Contracts, Arrangements, Understandings or
Relationships with Respect to Securities
of the Issuer None.


Item
7.
Material to Be Filed as Exhibits: None

Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct.


Date  02/14/2011



JOINT FILING AGREEMENT

This will conform the agreement by and among the undersigned
 that the Schedule 13D filed with the Securities and Exchange
Commission on or about the date hereof with respect to the beneficial
ownership by the undersigned of the Common Stock, $.001 par value,
of Benda Pharmaceuticals, Inc., is being filed, and all amendments
thereto will be filed, on behalf of each of the persons and entities
named below in a accordance with Rule 13d-1(k) under the Securities
Exchange Act of 1934, as amended.  This Agreement may be executed in
two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.

Dated:  February 14, 2011

POPE INVESTMENTS LLC
By:Pope Investments LLC /s/ William P. Wells, Managing Member
By:Pope Asset Management, LLC, /s/William P. Wells, President
By:WILIAM P. WELLS /s/William P. Wells Signature

POPE ASSET MANAGMENT LLC
By:Pope Investments LLC /s/ William P. Wells, Managing Member
By:Pope Asset Management, LLC, /s/William P. Wells, President
By:WILIAM P. WELLS /s/William P. Wells Signature

Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement
is true, complete and correct.